Targeted treatment of inflammatory diseases of the central nervous system (CNS) remains problematic due to the complex pathogenesis of these disorders and difficulty in drug delivery. The plant virus, cowpea mosaic virus (CPMV), has recently been explored as a nanoparticle delivery system for therapeutics targeting a number of diseases including cancer and neurodegeneration. To understand the biodistribution of CPMV in the CNS, we examined CPMV uptake during infection of mice with neurotropic mouse hepatitis virus (MHV). CPMV localized mainly to the CNS endothelium in areas that contained an intact blood brain barrier. However, in inflammatory lesions containing macrophage/microglial cell infiltration and IgG, CPMV could be detected in the brain parenchyma. Furthermore, CPMV showed rapid internalization in an in vitro model of the BBB. These results suggest that CPMV particles could be used as a vehicle to deliver therapeutics to the damaged CNS during neurodegenerative and infectious diseases of the CNS.
Introduction
The use of viruses as nanoparticles has the potential to revolutionize targeted drug delivery and imaging technologies. A number of viruses are currently under study for their ability to be easily modified to carry drug cargos or to target specific tissues of the body (Muldoon et al., 1995; Raty et al., 2006) . Delivery of drugs or gene therapy vectors to the central nervous system (CNS) has been particularly challenging.
Unlike peripheral organs, the CNS is protected from the diffusion of large particles from the circulation by the blood brain barrier (BBB). The BBB is composed of tight junctions consisting of integral transmembrane proteins; the claudins, occludins, and junctional adhesion molecules (Persidsky et al., 2006) . In addition, CNS endothelial cells express multidrug resistant proteins, P-glycoprotein, and members of the ATP-binding cassette transporters that facilitate the elimination of drugs, toxins, and metabolites from the brain parenchyma (Loscher and Potschka, 2005) . These mechanisms not only prevent the accumulation of toxic metabolites in the CNS, but also inhibit the effective treatment of diseases such as cancer and infection.
Several strategies using both viral and non-viral nanoparticles have been developed to aid in the delivery of therapies to the CNS. Silica nanoparticles, baculovirus, and TAT-conjugated polymers have all been used to target HIV drugs or gene therapy vectors to the brain (Bharali et al., 2005; Rao et al., 2008; Raty et al., 2006) . However, the biodistribution of these particles varies greatly, and most show uptake by a limited number of cell types or must be administered directly into the brain.
The plant virus, CPMV, is a member of the genus comovirus and is part of the Picornaviridae superfamily. CPMV is an attractive candidate for nanotechnology applications because of its excellent bioavailability. The virus is non-toxic even at high doses (up to 10 16 particles/ kg of body weight) and distributes to multiple organs after injection into animals (Rae et al., 2005; Singh et al., 2007) . Reactive lysines and cysteines on the surface of the capsid can be conjugated to fluorescent dyes and metals such as gadolinium for use in imaging studies or peptide ligands for use in vaccine applications and targeted drug delivery (Destito et al., 2007; Lewis et al., 2006; McLain et al., 1996; Singh et al., 2007) . These qualities make CPMV well-suited to manipulation as a nanoparticle for targeted in vivo delivery of therapeutics. Previous work examining the biodistribution of CPMV nanoparticles after oral or intravenous administration into mice showed robust accumulation in the normal CNS by RT-PCR and by detection of fluorescently-labeled particles, even in perfused animals (Rae et al., 2005) . In addition, CPMV has been shown to associate to the mammalian endothelium through an interaction with a 54 kD protein found on the surface of cells (Koudelka et al., 2007) . However, it is unknown if CPMV interacts with endothelial cells of the CNS, and whether inflammatory conditions can affect its localization.
To study localization of CPMV in a model of CNS inflammation, we used mice infected with neurotropic mouse hepatitis virus (MHV) (Fig. 1A) . A member of the family Coronaviridae, MHV is an enveloped postitive-stranded RNA virus and commonly used as an animal model Journal of Neuroimmunology 211 (2009) 66-72 
